【摘要】 目的:评价康莱特注射液治疗老年晚期非小细胞肺癌的临床疗效。方法:回顾分析采用康莱特注射液治疗102例老年晚期非小细胞肺癌患者的临床资料,观察肿瘤疾病控制率、治疗进展时间、生活质量、中医临床症状及毒副反应。结果:疾病控制率为65.69%,治疗进展时间2.91±0.51个月,可改善中医临床症状(P<0.01),无明显毒副反应。结论:康莱特注射液对老年晚期非小细胞肺癌患者具有较好的临床疗效。更多还原

【Abstract】 Objective: To evaluate the clinical efficacy of KangLaiTe Injection on advanced non-small cell lung cancer(NSCLC) senile patients.Methods: Clinical materials of 102 advanced NSCLC senile patients were analyzed retrospectively to study cancer disease control rate,disease progression time,quality of time,clinical symptom change and side effects.Results: The disease control rate was 65.69%,disease progression time 2.91±0.51 months,clinical symptom improved with P<0.01 and without evident side effect.Conclusion: KangLaiTe Injection demonstrated good clinical efficacy on advanced NSCLC senile patients.更多还原